Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge
Histologically, cells having vacuolated cytoplasm rich in mucin and pushing the nucleus to the periphery are indicative of signet ring cell carcinoma. This condition often affects the digestive system. On the other hand, it is a very uncommon subtype of invasive lobular breast carcinoma, with a high...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2023-07, Vol.15 (7) |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | |
container_title | Curēus (Palo Alto, CA) |
container_volume | 15 |
creator | Akouh, Nada Karich, Nassira Haloui, Anass Aissaoui, Asmae Zazour, Abdelkrim Ismaili, Zahi Bennani, Amal |
description | Histologically, cells having vacuolated cytoplasm rich in mucin and pushing the nucleus to the periphery are indicative of signet ring cell carcinoma. This condition often affects the digestive system. On the other hand, it is a very uncommon subtype of invasive lobular breast carcinoma, with a higher probability (more than invasive breast carcinoma of no special type {IBC-NST}) to migrate to the stomach, spleen, urinary tract, and uterus.As with other metastatic carcinomas of breast origin, metastatic signet ring cell carcinoma of the breast is often treated with systemic therapies such as chemotherapy or hormonal therapy. However, surgical resection and eventual perioperative chemotherapy are usually recommended in case of primary gastric ring cell carcinomas that are non-metastatic. As a result, misdiagnosis might result in unneeded gastrectomy and chemotherapy, which would result in considerable mortality and morbidity.We report a case of mammary lobular carcinoma with signet ring cells metastatic to the stomach, a variant rarely described and challenging to distinguish from primary gastric signet ring carcinoma. |
doi_str_mv | 10.7759/cureus.42502 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10457213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2859495694</sourcerecordid><originalsourceid>FETCH-LOGICAL-c244t-d6738f99628bee80400f73ae7cb5ebaf6493d386de8fb9cadf0b3d8f1e7aef1c3</originalsourceid><addsrcrecordid>eNplkV9LwzAUxYsoOHRvfoCAr3YmbdqkvsioOoWJ4h98DGl602V0zUxaYd_ezg6Z-HQv3N85915OEJwRPGEsyS5V56DzExolODoIRhFJecgJp4d7_XEw9n6JMSaYRZjhUbB5dmYl3QbNpG-dUejVVA206MU0FcqhrlEunTKNXUlkHXqEtudk24NzW3S1dHvzD9Mu_un9FZqiGyOrxvqtLF_IuoamgtPgSMvaw3hXT4L3u9u3_D6cP80e8uk8VBGlbVimLOY6y9KIFwAcU4w1iyUwVSRQSJ3SLC5jnpbAdZEpWWpcxCXXBJgETVR8ElwPvuuuWEGpoGmdrMV6-FtYacTfSWMWorJfgmCasIjEvcP5zsHZzw58K5a2c01_tIh4ktEsSTPaUxcDpZz13oH-XUGw2CYkhoTET0LxN98-iAc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2859495694</pqid></control><display><type>article</type><title>Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Akouh, Nada ; Karich, Nassira ; Haloui, Anass ; Aissaoui, Asmae ; Zazour, Abdelkrim ; Ismaili, Zahi ; Bennani, Amal</creator><creatorcontrib>Akouh, Nada ; Karich, Nassira ; Haloui, Anass ; Aissaoui, Asmae ; Zazour, Abdelkrim ; Ismaili, Zahi ; Bennani, Amal</creatorcontrib><description>Histologically, cells having vacuolated cytoplasm rich in mucin and pushing the nucleus to the periphery are indicative of signet ring cell carcinoma. This condition often affects the digestive system. On the other hand, it is a very uncommon subtype of invasive lobular breast carcinoma, with a higher probability (more than invasive breast carcinoma of no special type {IBC-NST}) to migrate to the stomach, spleen, urinary tract, and uterus.As with other metastatic carcinomas of breast origin, metastatic signet ring cell carcinoma of the breast is often treated with systemic therapies such as chemotherapy or hormonal therapy. However, surgical resection and eventual perioperative chemotherapy are usually recommended in case of primary gastric ring cell carcinomas that are non-metastatic. As a result, misdiagnosis might result in unneeded gastrectomy and chemotherapy, which would result in considerable mortality and morbidity.We report a case of mammary lobular carcinoma with signet ring cells metastatic to the stomach, a variant rarely described and challenging to distinguish from primary gastric signet ring carcinoma.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.42502</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Biopsy ; Breast cancer ; Case reports ; Case studies ; Chemotherapy ; Cytokeratin ; Endocrine therapy ; Endoscopy ; Estrogens ; Gastroenterology ; Histopathology ; Mammography ; Medical diagnosis ; Metastasis ; Obstetrics/Gynecology ; Pathology ; Pharmacy ; Tumors</subject><ispartof>Curēus (Palo Alto, CA), 2023-07, Vol.15 (7)</ispartof><rights>Copyright © 2023, Akouh et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2023, Akouh et al. 2023 Akouh et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c244t-d6738f99628bee80400f73ae7cb5ebaf6493d386de8fb9cadf0b3d8f1e7aef1c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457213/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457213/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Akouh, Nada</creatorcontrib><creatorcontrib>Karich, Nassira</creatorcontrib><creatorcontrib>Haloui, Anass</creatorcontrib><creatorcontrib>Aissaoui, Asmae</creatorcontrib><creatorcontrib>Zazour, Abdelkrim</creatorcontrib><creatorcontrib>Ismaili, Zahi</creatorcontrib><creatorcontrib>Bennani, Amal</creatorcontrib><title>Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge</title><title>Curēus (Palo Alto, CA)</title><description>Histologically, cells having vacuolated cytoplasm rich in mucin and pushing the nucleus to the periphery are indicative of signet ring cell carcinoma. This condition often affects the digestive system. On the other hand, it is a very uncommon subtype of invasive lobular breast carcinoma, with a higher probability (more than invasive breast carcinoma of no special type {IBC-NST}) to migrate to the stomach, spleen, urinary tract, and uterus.As with other metastatic carcinomas of breast origin, metastatic signet ring cell carcinoma of the breast is often treated with systemic therapies such as chemotherapy or hormonal therapy. However, surgical resection and eventual perioperative chemotherapy are usually recommended in case of primary gastric ring cell carcinomas that are non-metastatic. As a result, misdiagnosis might result in unneeded gastrectomy and chemotherapy, which would result in considerable mortality and morbidity.We report a case of mammary lobular carcinoma with signet ring cells metastatic to the stomach, a variant rarely described and challenging to distinguish from primary gastric signet ring carcinoma.</description><subject>Biopsy</subject><subject>Breast cancer</subject><subject>Case reports</subject><subject>Case studies</subject><subject>Chemotherapy</subject><subject>Cytokeratin</subject><subject>Endocrine therapy</subject><subject>Endoscopy</subject><subject>Estrogens</subject><subject>Gastroenterology</subject><subject>Histopathology</subject><subject>Mammography</subject><subject>Medical diagnosis</subject><subject>Metastasis</subject><subject>Obstetrics/Gynecology</subject><subject>Pathology</subject><subject>Pharmacy</subject><subject>Tumors</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNplkV9LwzAUxYsoOHRvfoCAr3YmbdqkvsioOoWJ4h98DGl602V0zUxaYd_ezg6Z-HQv3N85915OEJwRPGEsyS5V56DzExolODoIRhFJecgJp4d7_XEw9n6JMSaYRZjhUbB5dmYl3QbNpG-dUejVVA206MU0FcqhrlEunTKNXUlkHXqEtudk24NzW3S1dHvzD9Mu_un9FZqiGyOrxvqtLF_IuoamgtPgSMvaw3hXT4L3u9u3_D6cP80e8uk8VBGlbVimLOY6y9KIFwAcU4w1iyUwVSRQSJ3SLC5jnpbAdZEpWWpcxCXXBJgETVR8ElwPvuuuWEGpoGmdrMV6-FtYacTfSWMWorJfgmCasIjEvcP5zsHZzw58K5a2c01_tIh4ktEsSTPaUxcDpZz13oH-XUGw2CYkhoTET0LxN98-iAc</recordid><startdate>20230726</startdate><enddate>20230726</enddate><creator>Akouh, Nada</creator><creator>Karich, Nassira</creator><creator>Haloui, Anass</creator><creator>Aissaoui, Asmae</creator><creator>Zazour, Abdelkrim</creator><creator>Ismaili, Zahi</creator><creator>Bennani, Amal</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20230726</creationdate><title>Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge</title><author>Akouh, Nada ; Karich, Nassira ; Haloui, Anass ; Aissaoui, Asmae ; Zazour, Abdelkrim ; Ismaili, Zahi ; Bennani, Amal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c244t-d6738f99628bee80400f73ae7cb5ebaf6493d386de8fb9cadf0b3d8f1e7aef1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biopsy</topic><topic>Breast cancer</topic><topic>Case reports</topic><topic>Case studies</topic><topic>Chemotherapy</topic><topic>Cytokeratin</topic><topic>Endocrine therapy</topic><topic>Endoscopy</topic><topic>Estrogens</topic><topic>Gastroenterology</topic><topic>Histopathology</topic><topic>Mammography</topic><topic>Medical diagnosis</topic><topic>Metastasis</topic><topic>Obstetrics/Gynecology</topic><topic>Pathology</topic><topic>Pharmacy</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akouh, Nada</creatorcontrib><creatorcontrib>Karich, Nassira</creatorcontrib><creatorcontrib>Haloui, Anass</creatorcontrib><creatorcontrib>Aissaoui, Asmae</creatorcontrib><creatorcontrib>Zazour, Abdelkrim</creatorcontrib><creatorcontrib>Ismaili, Zahi</creatorcontrib><creatorcontrib>Bennani, Amal</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akouh, Nada</au><au>Karich, Nassira</au><au>Haloui, Anass</au><au>Aissaoui, Asmae</au><au>Zazour, Abdelkrim</au><au>Ismaili, Zahi</au><au>Bennani, Amal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2023-07-26</date><risdate>2023</risdate><volume>15</volume><issue>7</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Histologically, cells having vacuolated cytoplasm rich in mucin and pushing the nucleus to the periphery are indicative of signet ring cell carcinoma. This condition often affects the digestive system. On the other hand, it is a very uncommon subtype of invasive lobular breast carcinoma, with a higher probability (more than invasive breast carcinoma of no special type {IBC-NST}) to migrate to the stomach, spleen, urinary tract, and uterus.As with other metastatic carcinomas of breast origin, metastatic signet ring cell carcinoma of the breast is often treated with systemic therapies such as chemotherapy or hormonal therapy. However, surgical resection and eventual perioperative chemotherapy are usually recommended in case of primary gastric ring cell carcinomas that are non-metastatic. As a result, misdiagnosis might result in unneeded gastrectomy and chemotherapy, which would result in considerable mortality and morbidity.We report a case of mammary lobular carcinoma with signet ring cells metastatic to the stomach, a variant rarely described and challenging to distinguish from primary gastric signet ring carcinoma.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><doi>10.7759/cureus.42502</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Curēus (Palo Alto, CA), 2023-07, Vol.15 (7) |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10457213 |
source | PubMed Central Open Access; PubMed Central |
subjects | Biopsy Breast cancer Case reports Case studies Chemotherapy Cytokeratin Endocrine therapy Endoscopy Estrogens Gastroenterology Histopathology Mammography Medical diagnosis Metastasis Obstetrics/Gynecology Pathology Pharmacy Tumors |
title | Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20Gastric%20Signet%20Ring%20Cell%20Carcinoma%20or%20Metastatic%20Lobular%20Carcinoma%20With%20Signet%20Ring%20Cells:%20A%20Diagnostic%20Challenge&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Akouh,%20Nada&rft.date=2023-07-26&rft.volume=15&rft.issue=7&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.42502&rft_dat=%3Cproquest_pubme%3E2859495694%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2859495694&rft_id=info:pmid/&rfr_iscdi=true |